C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2011
12/13/2011	US8076452 Streptavidin-binding peptide
12/13/2011	US8076451 Translocation of impermeable molecules (peptides, toxins, drugs, inhibitors, nucleic acids, peptide nucleic acids, imaging probes) into cells at low pH; tumors, infarction, stroke, atherosclerosis, inflammation, infection, or trauma
12/13/2011	US8076450 Administering an acid sensing ion channel inhibitor; therapy or prevention of brain injuries
12/13/2011	US8076449 polypeptide containing an amino acid sequence represented by Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala-Pro-Ala-Gly-Ala-Ser-Arg-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro; or having a deletion, substitution, insertion of above sequence or modified polypeptide; Alzheimer's disease, amyotrophic lateral sclerosis
12/13/2011	US8076412 Water-soluble polymer alkanals
12/13/2011	US8076300 FGF2-binding peptides and uses thereof
12/13/2011	US8076294 Collagen-related peptides and uses thereof
12/13/2011	US8076292 Factor VIII: remodeling and glycoconjugation of factor VIII
12/13/2011	US8076291 Treatment for obesity
12/13/2011	US8076148 Cytochrome c protein and assay
12/13/2011	US8076138 Evolution of whole cells and organisms by recursive sequence recombination
12/13/2011	US8076131 Settings for recombinant adenoviral-based vaccines
12/13/2011	US8076116 Nucleic acids encoding class II human histone deacetylases, and uses related thereto
12/13/2011	US8076115 Polypeptides having phytase activity and polynucleotides encoding same
12/13/2011	US8076101 Method of detecting the cystic fibrosis transmembrane conductance regulator (CFTR) at cell exterior
12/13/2011	US8076100 Genetic engineering; vaccine; induction antibodies
12/13/2011	US8076096 Alteration of cell membrane with FasL
12/13/2011	US8076091 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof
12/13/2011	US8076089 Biomarkers for liver diseases and method for using the same
12/13/2011	US8076087 Galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
12/13/2011	US8076086 Methods of modulating the activity of TANGO332
12/13/2011	US8075922 Method of co-infusing a deoxygenated hemoglobin containing blood substitute and inorganic nitrite
12/13/2011	US8075900 Melanoma associated peptide analogues and vaccines against melanoma
12/13/2011	US8075898 Mite allergen
12/13/2011	US8075897 Allergen peptide fragments and use thereof
12/13/2011	US8075895 Identification of antigenic peptides from multiple myeloma cells
12/13/2011	US8075892 Treatment with anti-ErbB2 antibodies
12/13/2011	US8075888 Methods of treatment using antibodies to IL-17 homologous polypeptides
12/13/2011	US8075886 Method of treatment using an anti-IL-B50 antibody
12/13/2011	US8075562 Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery
12/13/2011	CA2606758C High beta-conglycinin products and their use
12/13/2011	CA2475821C Group b streptococcus antigens
12/13/2011	CA2470743C Corticotropin releasing factor 2 receptor agonists
12/13/2011	CA2446197C Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an act polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances
12/13/2011	CA2410663C A cytochrome p450 enzyme associated with the synthesis of .delta. 12-epoxy groups in fatty acids of plants
12/13/2011	CA2402238C Polypeptides having neutrophil stimulating activity
12/13/2011	CA2373071C Tapetum-specific promoters
12/13/2011	CA2358520C Soluble receptor br43x2 and methods of using
12/13/2011	CA2267851C Bordetella strain expressing the fha hybrid, liposomes and vaccines
12/13/2011	CA2229203C Antigenic preparations from keratinophilic fungi
12/08/2011	WO2011153531A1 Method of treating skeletal dysplasias using vessel dilator
12/08/2011	WO2011153522A2 Compounds and methods for fret based measurement of enzyme activity
12/08/2011	WO2011153512A2 Use of compounds with thrombopoietic activity to promote bone growth and healing
12/08/2011	WO2011153491A2 Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets
12/08/2011	WO2011153469A1 Markers for renal disease
12/08/2011	WO2011153317A1 C4 dicarboxylic acid production in filamentous fungi
12/08/2011	WO2011153253A1 Electronic and biological pacemaker systems
12/08/2011	WO2011152742A2 Feed additive of antimicrobial properties, concentrate, use of feed additive to obtain concentrate and method of manufacturing feed additive
12/08/2011	WO2011152568A1 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family, having attenuated expression of genes encoding a lysine/arginine/ornithine transporter
12/08/2011	WO2011152554A1 Method for producing tumor cell
12/08/2011	WO2011151832A1 Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof
12/08/2011	WO2011151716A1 Process for the purification of recombinant human il-11
12/08/2011	WO2011151425A1 Methods and strains for the production of sarcinaxanthin and derivatives thereof
12/08/2011	WO2011151407A1 Fraction of proteins and peptides derived from egg white and protein derived from egg white and use thereof as anti-listeria agent
12/08/2011	WO2011151403A1 Improved cancer therapy based on tumor associated antigens derived from cyclin d1
12/08/2011	WO2011151341A1 Lactadherin-derived peptides as antiviral agents
12/08/2011	WO2011151333A1 Papillomavirus l2 c-terminal peptides for vaccination
12/08/2011	WO2011150999A1 A genetically modified bacterium of the species listeria monocytogenes
12/08/2011	WO2011150944A1 Trefoil factors (tff) for the treatment of chronic pulmonary diseases
12/08/2011	WO2011150517A2 Biomarker for diagnosis and treatment of colorectal cancer
12/08/2011	WO2011150495A1 Rhamm binding peptides
12/08/2011	WO2011150470A1 Vitronectin:keratinocyte growth factor chimeras
12/08/2011	WO2011103666A8 Modulation of cytokine-induced chronic inflammatory responses
12/08/2011	WO2011101681A3 Disulphide bond-stabilized functional soluble mhc class ii heterodimers
12/08/2011	WO2011090272A3 OsMPT GENE MODIFYING PLANT ARCHITECTURE (PLANT SHAPE) AND INCREASING YIELD, AND USE THEREOF
12/08/2011	WO2011083500A3 Method of use of stabilized plant-derived growth factor in skin care
12/08/2011	WO2011063165A9 Methods and compositions for capture of cells
12/08/2011	WO2010087743A8 The use of basigin-1 in stem cell and cancer applications
12/08/2011	US20110302674 Methods and Compositions for the Improvement of Plant Tolerance to Environmental Stresses
12/08/2011	US20110302671 Embryo sac-specific genes
12/08/2011	US20110301341 Modified organs and cells for xenotransplantation
12/08/2011	US20110301340 Toxins and Radionuclides Coupled to IGF-1 Receptor Ligands for Treatment of Cancer
12/08/2011	US20110301339 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301338 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301337 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110301329 Process for the Purification of Recombinant Albumin
12/08/2011	US20110301328 Polyvalent vaccine
12/08/2011	US20110301216 Anticancer and antimicrobial compounds from antarctic extremophilic microorgansims
12/08/2011	US20110301131 Drug Delivery Implants and Processes for Their Preparation
12/08/2011	US20110301097 Oral Administration Of Therapeutic Agent Coupled To Transporting Agent
12/08/2011	US20110301094 New tumor suppressor gene, p28ing5
12/08/2011	US20110301093 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/08/2011	US20110301092 The use of a non-glycanated polypeptide for treating a cancer
12/08/2011	US20110301087 Crf1 receptor compounds
12/08/2011	US20110301084 Protracted Exendin-4 Compounds
12/08/2011	US20110301083 Conjugate based systems for controlled drug delivery
12/08/2011	US20110301079 Neuromedin u receptor agonists and uses thereof
12/08/2011	US20110301077 Method for production of lactoferrin
12/08/2011	US20110301074 Protein preparation produced from rape seeds
12/08/2011	US20110301073 Novel DNA-binding proteins and uses thereof
12/08/2011	US20110301057 In situ oriented immobilization of proteins on a support
12/08/2011	US20110300642 Methods for differentiating and monitoring parathyroid and bone status related diseases
12/08/2011	US20110300641 Protein isoforms for diagnosis
12/08/2011	US20110300629 TRAIL trimers, methods and uses therefor
12/08/2011	US20110300600 Methods and compositions for delivering polynucleotides
12/08/2011	US20110300578 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300577 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
12/08/2011	US20110300560 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
12/08/2011	US20110300558 Nanoparticle for bioaffinity assays
12/08/2011	US20110300180 plant-derived vaccines against respiratory syncytial virus

1 ... 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 ... 2916